Personal Health
New treatments emerge for chronic hives
Persephone Blackwood · October 12, 2026
New treatments emerge for chronic hives, including advances in interleukin receptor blockade.
01
02
03
04
05
Kaiser Permanente and UnitedHealthcare lead Medicare Advantage member satisfaction rankings in the 2026 JD Power study, with scores dropping 12 points.
New treatments emerge for chronic hives, including advances in interleukin receptor blockade.
MedPage Today journalists have collected a series of honors that underline the outlet’s role in delivering reliable medical…
Most teen colorectal cancer cases are identified at later stages, with 80% presenting as stage III or IV,…
Maternal health issues during pregnancy may be linked to autism spectrum disorder in children, according to a U.S.…
A strict diet and exercise may reverse early type 2 diabetes in half of young adults, according to…
Medical debt is linked to higher late-stage cancer diagnoses, including lung cancer cases per 100,000 person-years.
A woman's swallowed nails were successfully removed via colonoscopy after lodging in her ileocecal valve, marking her sixth…
CMS shifts Medicaid focus to patient outcomes over process metrics, encouraging states to track prevention and chronic disease…
Cigna uses AI to aid cancer patients with tailored assistance and treatment plans.
Hospitals reduce claim denials but still lose money as insurers claw back more from approved payments in 2026,…
